The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1212
ISSUE1212
July 4, 2005
CYP3A and Drug Interactions
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
CYP3A and Drug Interactions
July 4, 2005 (Issue: 1212)
Serious adverse interactions between drugs continue to be reported. Many of these are due to inhibition or induction of cytochrome P450 (CYP) enzymes, particularly CYP3A4. CYP3A is thought to be involved in the metabolism of more than 50 percent of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.